Click it and Unblock the Notifications
സെൻസെക്സ്
73,583.22
-2.25%
|
നിഫ്റ്റി
22,819.60
-2.09%
|
സ്വർണ്ണം
₹ 13,575 /gm
|
വെള്ളി
₹ 2,50,000/kg
|
പെട്രോൾ
₹ 107.48
|
ഡീസൽ
₹ 96.38
|
ക്രൂഡ് ഓയിൽ
$105.02
|
USD
₹
94.78
|
സെൻസെക്സ്
73,583.22
-2.25%
|
നിഫ്റ്റി
22,819.60
-2.09%
|
സ്വർണ്ണം
₹ 13,575 /gm
|
വെള്ളി
₹ 2,50,000/kg
|
പെട്രോൾ
₹ 107.48
|
ഡീസൽ
₹ 96.38
|
ക്രൂഡ് ഓയിൽ
$105.02
|
USD
₹
94.78
|
സെൻസെക്സ്
73,583.22
-2.25%
|
നിഫ്റ്റി
22,819.60
-2.09%
|
സ്വർണ്ണം
₹ 13,575 /gm
|
വെള്ളി
₹ 2,50,000/kg
|
പെട്രോൾ
₹ 107.48
|
ഡീസൽ
₹ 96.38
|
ക്രൂഡ് ഓയിൽ
$105.02
|
USD
₹
94.78
ITI Pharma and Healthcare Fund - Direct Plan
Regular
Direct
3 Year Absolute Returns
79.41% ↑
NAV (₹) on 27 Mar 2026
16.34
1 Day NAV Change
-0.79%
Risk Level
Very High Risk
Rating
-
ITI Pharma and Healthcare Fund - Direct Plan is a Equity mutual fund categorized under Sector, offered by ITI Asset Management Limited. Launched on 18 Oct 2021, investors can start with a minimum SIP ... Read more
NAV History
Fund Details
Min. SIP Amount
₹500
Inception Date
18 Oct 2021
Min. Lumpsum Amount
₹ 5,000
Fund Age
4 Yrs
AUM
₹ 221.78 Cr.
Benchmark
NIFTY Healthcare Total Return Index
Expense Ratio
0.47%
Scheme Type
Open Ended
Exit Load
0.5%
Returns Calculator
Investment amount per month
₹1,000
Over the past
Would have become
On total investment of
*Calculation based on past performance of this fund.
Asset Allocation
AUM
₹ 221.78 Cr
Equity
198.97%
Other Assets & Liabilities
1.03%
Sector Holdings
| Sectors | Weightage |
|---|---|
| Pharmaceuticals | 67.48% |
| Hospitals & Medical Services | 23.33% |
| Finance - Life Insurance | 1.36% |
| Industrial Gases | 1.30% |
| Agro Chemicals/Pesticides | 1.22% |
| Equity | 1.05% |
| Plastics - Plastic & Plastic Products | 0.99% |
| Agricultural Products | 0.94% |
| Engineering - Heavy | 0.92% |
| Net Receivables/(Payables) | 0.73% |
| Medical Equipment & Accessories | 0.68% |
Stock Holdings
| Name | Weightage | Value (in Cr.) | Sector |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | 11.12% | ₹ 24.66 | Pharmaceuticals |
| Divi's Laboratories Limited | 9.01% | ₹ 19.98 | Pharmaceuticals |
| Apollo Hospitals Enterprise Limited | 6.62% | ₹ 14.69 | Hospitals & Medical Services |
| Max Healthcare Institute Limited | 5.94% | ₹ 13.18 | Hospitals & Medical Services |
| Torrent Pharmaceuticals Limited | 5.17% | ₹ 11.46 | Pharmaceuticals |
| Aurobindo Pharma Limited | 4.45% | ₹ 9.87 | Pharmaceuticals |
| Fortis Healthcare Limited | 3.85% | ₹ 8.53 | Hospitals & Medical Services |
| Lupin Limited | 3.74% | ₹ 8.30 | Pharmaceuticals |
| Alkem Laboratories Limited | 3.17% | ₹ 7.02 | Pharmaceuticals |
| Aster DM Healthcare Limited | 3.16% | ₹ 7.01 | Hospitals & Medical Services |
| Neuland Laboratories Limited | 2.70% | ₹ 5.99 | Pharmaceuticals |
| Abbott India Limited | 2.26% | ₹ 5.01 | Pharmaceuticals |
| Glenmark Pharmaceuticals Limited | 2.05% | ₹ 4.55 | Pharmaceuticals |
| Cohance Lifesciences Limited | 2.04% | ₹ 4.53 | Pharmaceuticals |
| Laurus Labs Limited | 2.01% | ₹ 4.45 | Pharmaceuticals |
| Mankind Pharma Limited | 1.98% | ₹ 4.39 | Pharmaceuticals |
| Dr. Reddy's Laboratories Limited | 1.83% | ₹ 4.06 | Pharmaceuticals |
| Sai Life Sciences Limited | 1.78% | ₹ 3.95 | Pharmaceuticals |
| Cipla Limited | 1.75% | ₹ 3.88 | Pharmaceuticals |
| IPCA Laboratories Limited | 1.55% | ₹ 3.44 | Pharmaceuticals |
| Park Medi World Limited | 1.45% | ₹ 3.21 | Hospitals & Medical Services |
| SBI Life Insurance Company Limited | 1.36% | ₹ 3.02 | Finance - Life Insurance |
| Biocon Limited | 1.33% | ₹ 2.95 | Pharmaceuticals |
| Linde India Limited | 1.30% | ₹ 2.89 | Industrial Gases |
| Healthcare Global Enterprises Limited | 1.23% | ₹ 2.72 | Hospitals & Medical Services |
| FDC Limited | 1.23% | ₹ 2.72 | Pharmaceuticals |
| Sumitomo Chemical India Limited | 1.22% | ₹ 2.70 | Agro Chemicals/Pesticides |
| Piramal Pharma Limited | 1.15% | ₹ 2.55 | Pharmaceuticals |
| Rainbow Childrens Medicare Limited | 1.08% | ₹ 2.40 | Hospitals & Medical Services |
| GlaxoSmithKline Pharmaceuticals Limited | 1.07% | ₹ 2.37 | Pharmaceuticals |
| TREPS 02-Mar-2026 | 1.05% | ₹ 2.34 | Others |
| Orchid Pharma Limited | 1.01% | ₹ 2.25 | Pharmaceuticals |
| Onesource Specialty Pharma Limited | 1.00% | ₹ 2.22 | Pharmaceuticals |
| Shaily Engineering Plastics Limited | 0.99% | ₹ 2.19 | Plastics - Plastic & Plastic Products |
| Jubilant Ingrevia Limited | 0.94% | ₹ 2.08 | Agricultural Products |
| Standard Engineering Technology Ltd | 0.92% | ₹ 2.04 | Engineering - Heavy |
| Caplin Point Laboratories Limited | 0.80% | ₹ 1.78 | Pharmaceuticals |
| Shilpa Medicare Limited | 0.75% | ₹ 1.67 | Pharmaceuticals |
| AstraZeneca Pharma India Limited | 0.75% | ₹ 1.66 | Pharmaceuticals |
| Supriya Lifescience Limited | 0.75% | ₹ 1.66 | Pharmaceuticals |
| Net Receivables / (Payables) | 0.73% | ₹ 1.63 | Others |
| Zydus Lifesciences Limited | 0.70% | ₹ 1.55 | Pharmaceuticals |
| Poly Medicure Limited | 0.68% | ₹ 1.51 | Medical Equipment & Accessories |
| Syngene International Limited | 0.33% | ₹ 0.72 | Pharmaceuticals |
Returns
| Annualised returns | ||||
|---|---|---|---|---|
| 9M | 1Y | 2Y | 3Y | |
| Fund returns | -7.02% | -2.25% | 7.85% | 21.51% |
| Category returns | -6.96% | 1.07% | 6.24% | 23.23% |
Fund Objective
The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare. ... Read more
AMC Details
Name
ITI Asset Management Limited
Date of Incorporation
14 May 2018
CEO
Mr. Jatinder Pal Singh
CIO
Mr. Rajesh Bhatia
Type
Pvt.Sector-Indian
Address
ITI House 36,
Dr. R. K. Shirodkar Marg,
Parel Mumbai, Maharashtra, India - 400012
Website
https://www.itiamc.com
Email
Top Funds from Equity - Sectoral/Thematic
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Canara Robeco Consumer Trends Fund - Direct Plan
Diversified
Direct
|
₹75.07 | -9.30% | 32.38% | 54.69% | ₹1,950 | 0.82% |
Very High
|
|
Quantum ESG Best In Class Strategy Fund
Diversified
Regular
|
₹20.89 | -6.99% | 32.30% | 47.42% | ₹95 | 2.18% |
Very High
|
|
DSP Quant Fund
Largecap
Regular
|
₹19.83 | -1.18% | 32.19% | 43.66% | ₹838 | 1.25% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹108.99 | -9.58% | 32.11% | 72.26% | ₹4,273 | 1.92% |
Very High
|
|
SBI Technology Opportunities Fund
Sector
Regular
|
₹180.99 | -9.58% | 32.10% | 72.24% | ₹4,273 | 1.92% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Diversified
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Axis Innovation Fund - Direct Plan
Sector
Direct
|
₹15.31 | -5.26% | 32.10% | 49.80% | ₹1,121 | 1.31% |
Very High
|
|
Tata Ethical Fund - Direct Plan
Sector
Direct
|
₹215.33 | -5.17% | 31.65% | 66.52% | ₹3,715 | 0.71% |
Very High
|
Top Funds from ITI Asset Management Limited
|
Scheme Name
|
NAV
|
Returns
1Y
3Y
5Y
|
AUM (Cr)
|
Expense Ratio
|
Risk Meter
|
||
|---|---|---|---|---|---|---|---|
|
ITI Overnight Fund
Liquid
Regular
|
₹1,001.30 | -0.00% | 0.03% | 0.01% | ₹47 | 0.18% |
Low
|
|
ITI Overnight Fund
Liquid
Regular
|
₹1,001.30 | -0.00% | 0.03% | 0.01% | ₹47 | 0.18% |
Low
|
|
ITI Overnight Fund - Direct Plan
Liquid
Direct
|
₹1,001.29 | -0.00% | 0.03% | 0.01% | ₹47 | 0.08% |
Low
|
|
ITI Overnight Fund - Direct Plan
Liquid
Direct
|
₹1,001.29 | -0.00% | 0.03% | 0.01% | ₹47 | 0.08% |
Low
|
|
ITI Balanced Advantage Fund
Hybrid
Regular
|
₹13.63 | -1.39% | 31.82% | 46.58% | ₹379 | 2.39% |
Moderately High
|
|
ITI Large Cap Fund
Diversified
Regular
|
₹14.79 | -11.63% | 29.41% | 39.30% | ₹507 | 2.35% |
Very High
|
|
ITI Large Cap Fund
Largecap
Regular
|
₹14.79 | -11.63% | 29.41% | 39.30% | ₹507 | 2.35% |
Very High
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.24 | 7.31% | 25.12% | 34.02% | ₹49 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.24 | 7.31% | 25.12% | 34.02% | ₹49 | 0.21% |
Low
|
|
ITI Arbitrage Fund - Direct Plan
Arbitrage
Direct
|
₹14.24 | 7.31% | 25.12% | 34.02% | ₹49 | 0.21% |
Low
|
FAQs
What is the current NAV of ITI Pharma and Healthcare Fund - Direct Plan Growth?
The current Net Asset Value (NAV) of ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹16.34 as of 27 Mar 2026. NAV represents the per-unit market value of the fund and is updated daily based on the closing prices of the underlying securities.
What is the fund size (AUM) of ITI Pharma and Healthcare Fund - Direct Plan Growth?
The Assets Under Management (AUM) of ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹221.78 Crores. AUM indicates the total market value of assets managed by the fund and reflects investor confidence and fund popularity.
What are the historical returns of ITI Pharma and Healthcare Fund - Direct Plan Growth?
ITI Pharma and Healthcare Fund - Direct Plan Growth has delivered returns of -2.25% (1 Year), 21.51% (3 Year), 0.00% (5 Year). Past performance does not guarantee future results, and investors should consider their risk appetite before investing.
What is the risk level of ITI Pharma and Healthcare Fund - Direct Plan Growth?
ITI Pharma and Healthcare Fund - Direct Plan Growth has a risk rating of 'Very High' as per the SEBI Riskometer. This indicates the fund is suitable for very aggressive investors comfortable with significant market volatility. Investors should align their investment choices with their personal risk tolerance and financial goals.
What is the minimum investment amount for ITI Pharma and Healthcare Fund - Direct Plan Growth?
The minimum lumpsum investment required for ITI Pharma and Healthcare Fund - Direct Plan Growth is ₹5,000. The fund also offers SIP (Systematic Investment Plan) option starting from as low as ₹500, making it accessible for regular investments. This allows investors to start their mutual fund journey with a manageable amount.
Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article
-
മ്യൂച്വല്ഫണ്ട് നിക്ഷേപങ്ങള്ക്ക് ഇനി അധിക സുരക്ഷ, സമ്പാദ്യം 'ലോക്ക്' ചെയ്യാം; വിശദാംശങ്ങള് -
എഫ്ഡി, ആർഡി, മ്യൂച്വൽ ഫണ്ട്, സ്വർണം; നേട്ടം കൊയ്യാൻ എവിടെ നിക്ഷേപിക്കണം? -
2026-ൽ മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപം നോക്കുന്നുണ്ടോ..? ഇതാ മികച്ച 5 എണ്ണം, കുട്ടികളുടെ ഭാവി സുരക്ഷിതമാക്കാം -
പുതുവർഷം തന്നെ തുടങ്ങാം, ലക്ഷങ്ങൾ സമ്പാദിക്കാൻ മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപം, ഇതാ 3 നിർദ്ദേശങ്ങൾ -
ജോലിയിൽ നിന്നും വിരമിക്കുമ്പോൾ 10 കോടി നേടാം, നിക്ഷേപം ഇങ്ങനെ ക്രമീകരിക്കൂ, വിശദമായി വായിക്കാം -
മ്യൂച്വൽ ഫണ്ട് നിക്ഷേപമുണ്ടോ? നിക്ഷേപം പിൻവലിക്കുമ്പോൾ നൽകേണ്ട നികുതി അറിയാം -
SSY vs PPF vs മ്യൂച്വൽ ഫണ്ട്: കുട്ടികളുടെ ഭാവി സുരക്ഷിതമാക്കാൻ നിക്ഷേപിക്കാവുന്ന മികച്ച പദ്ധതി ഏതാണ്? -
വിദ്യാഭ്യാസ ചിലവുകൾ വർദ്ധിക്കുന്നു, കുട്ടികൾക്കായി സാമ്പത്തിക നിക്ഷേപം വേണം, ഇതാ മാർഗങ്ങൾ -
150 രൂപ കൊണ്ട് 1 കോടി സമ്പാദിക്കാം,തള്ളിയതല്ല, സത്യമാണ്, ഇതാ നിക്ഷേപ രീതി -
Best SIP Mutual Funds: സമ്പാദ്യം വളർത്താൻ മികച്ചത് മ്യൂച്വൽ ഫണ്ട് തന്നെ, നേട്ടം 25 ശതമാനം വരെ, നോക്കുന്നോ..?
Top Mutual Fund House in India
Notifications
Settings
Clear Notifications
Notifications
Use the toggle to switch on notifications
-
Block for 8 hours
-
Block for 12 hours
-
Block for 24 hours
-
Don't block
Stay Informed.
Get news and videos anytime and anywhere.
Sign in with Google By signing in, you agree to our Terms and Privacy Policy
Gender
Select your Gender
- Male
- Female
- Others
Age
Select your Age Range
- Under 18
- 18 to 25
- 26 to 35
- 36 to 45
- 45 to 55
- 55+
X